435 related articles for article (PubMed ID: 34309078)
1. European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II.
Schmidt E; Rashid H; Marzano AV; Lamberts A; Di Zenzo G; Diercks GFH; Alberti-Violetti S; Barry RJ; Borradori L; Caproni M; Carey B; Carrozzo M; Cianchini G; Corrà A; Dikkers FG; Feliciani C; Geerling G; Genovese G; Hertl M; Joly P; Meijer JM; Mercadante V; Murrell DF; Ormond M; Pas HH; Patsatsi A; Rauz S; van Rhijn BD; Roth M; Setterfield J; Zillikens D; C Prost ; Zambruno G; Horváth B; Caux F
J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):1926-1948. PubMed ID: 34309078
[TBL] [Abstract][Full Text] [Related]
2. European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.
Rashid H; Lamberts A; Borradori L; Alberti-Violetti S; Barry RJ; Caproni M; Carey B; Carrozzo M; Caux F; Cianchini G; Corrà A; Diercks GFH; Dikkers FG; Di Zenzo G; Feliciani C; Geerling G; Genovese G; Hertl M; Joly P; Marzano AV; Meijer JM; Mercadante V; Murrell DF; Ormond M; Pas HH; Patsatsi A; Prost C; Rauz S; van Rhijn BD; Roth M; Schmidt E; Setterfield J; Zambruno G; Zillikens D; Horváth B
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1750-1764. PubMed ID: 34245180
[TBL] [Abstract][Full Text] [Related]
3. Mucous membrane pemphigoid.
Du G; Patzelt S; van Beek N; Schmidt E
Autoimmun Rev; 2022 Apr; 21(4):103036. PubMed ID: 34995762
[TBL] [Abstract][Full Text] [Related]
4. A Case of Anti-BP180-type Mucous Membrane Pemphigoid with IgG and IgA Autoantibodies Showing Distinct Reactivities.
Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Nakazawa M; Sawamura D
Acta Dermatovenerol Croat; 2022 Jul; 30(1):54-56. PubMed ID: 36153720
[TBL] [Abstract][Full Text] [Related]
5. Symmetrical Skin Lesions on the Gluteal Region in a Patient with Anti-Laminin-332 Mucous Membrane Pemphigoid.
Maki N; Demitsu T; Nagato H; Okada O; Yoneda K; Hashimoto T; Hasunuma N; Osada I; Manabe M
Acta Dermatovenerol Croat; 2021 Jul; 29(2):105-107. PubMed ID: 34477077
[TBL] [Abstract][Full Text] [Related]
6. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
[TBL] [Abstract][Full Text] [Related]
7. Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV).
Borradori L; Van Beek N; Feliciani C; Tedbirt B; Antiga E; Bergman R; Böckle BC; Caproni M; Caux F; Chandran NS; Cianchini G; Daneshpazhooh M; De D; Didona D; Di Zenzo GM; Dmochowski M; Drenovska K; Ehrchen J; Goebeler M; Groves R; Günther C; Horvath B; Hertl M; Hofmann S; Ioannides D; Itzlinger-Monshi B; Jedličková J; Kowalewski C; Kridin K; Lim YL; Marinovic B; Marzano AV; Mascaro JM; Meijer JM; Murrell D; Patsatsi K; Pincelli C; Prost C; Rappersberger K; Sárdy M; Setterfield J; Shahid M; Sprecher E; Tasanen K; Uzun S; Vassileva S; Vestergaard K; Vorobyev A; Vujic I; Wang G; Wozniak K; Yayli S; Zambruno G; Zillikens D; Schmidt E; Joly P
J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):1689-1704. PubMed ID: 35766904
[TBL] [Abstract][Full Text] [Related]
8. Case Report: Mucous Membrane Pemphigoid With IgG and IgA Anti-Laminin γ1 Antibodies and IgA Anti-Laminin α5 Antibodies.
Kuang W; Qian H; Zhang Q; Li W; Hashimoto T; Zeng X; Li X
Front Immunol; 2022; 13():903174. PubMed ID: 35720393
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody Detection for Diagnosis in Direct Immunofluorescence-Negative Mucous Membrane Pemphigoid: Ocular and Other Sites Compared.
Dart J; Setterfield J; Groves RW; Mee JB; Diercks GFH; Pas HH; Minassian D;
Ophthalmology; 2021 Mar; 128(3):372-382. PubMed ID: 32745569
[TBL] [Abstract][Full Text] [Related]
10. Case report: Mucous membrane pemphigoid with complicated autoantibody profile indicating the necessity of comprehensive diagnostic methods and the contribution of IgA autoantibodies.
Liu W; Li H; Jin Y; Cheng L; Shi L; Gao Y; Zhou Z; Feng S; Qian H; Hashimoto T; Li X
Front Immunol; 2023; 14():1149119. PubMed ID: 36969205
[TBL] [Abstract][Full Text] [Related]
11. Disease Endotypes Predict the Severity of Mucous Membrane Pemphigoid.
Fairley JA; Crowe TP; Fakhimi M; Palmer SJ; Greiner MA; Hellstein JW; Van Daele DJ; Messingham KN
J Invest Dermatol; 2023 Aug; 143(8):1479-1486.e3. PubMed ID: 36870557
[TBL] [Abstract][Full Text] [Related]
12. Development of pemphigus foliaceus in a mucous membrane pemphigoid patient: An insight into possible mechanism eliciting a distinct autoimmune bullous disease in a rare anti-basement membrane autoimmunity.
Shimoda-Komatsu Y; Fukui K; Yamazaki Y; Ohyama M
J Dermatol; 2021 May; 48(5):710-714. PubMed ID: 33725421
[TBL] [Abstract][Full Text] [Related]
13. Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis.
Yayli S; Pelivani N; Beltraminelli H; Wirthmüller U; Beleznay Z; Horn M; Borradori L
Br J Dermatol; 2011 Nov; 165(5):1133-7. PubMed ID: 21711326
[TBL] [Abstract][Full Text] [Related]
14. [Mucous membrane pemphigoid].
Holtsche MM; Zillikens D; Schmidt E
Hautarzt; 2018 Jan; 69(1):67-83. PubMed ID: 29242962
[TBL] [Abstract][Full Text] [Related]
15. Insights into clinical and diagnostic findings as well as treatment responses in patients with mucous membrane pemphigoid: A retrospective cohort study.
Rashid H; Meijer JM; Bolling MC; Diercks GFH; Pas HH; Horváth B
J Am Acad Dermatol; 2022 Jul; 87(1):48-55. PubMed ID: 34896128
[TBL] [Abstract][Full Text] [Related]
16. The Second Study of Clinical and Immunological Findings in Anti-laminin 332-Type Mucous Membrane Pemphigoid Examined at Kurume University-Diagnosis Criteria Suggested by Summary of 133 Cases.
Qian H; Natsuaki Y; Koga H; Kawakami T; Tateishi C; Tsuruta D; Ishii N; Li X; Hashimoto T
Front Immunol; 2021; 12():771766. PubMed ID: 34899722
[TBL] [Abstract][Full Text] [Related]
17. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
Raffin D; Delaplace M; Roussel A; Estève E
Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
[TBL] [Abstract][Full Text] [Related]
18. Immune-mediated subepithelial blistering diseases of mucous membranes. Pure ocular cicatricial pemphigoid is a unique clinical and immunopathological entity distinct from bullous pemphigoid and other subsets identified by antigenic specificity of autoantibodies.
Chan LS; Yancey KB; Hammerberg C; Soong HK; Regezi JA; Johnson K; Cooper KD
Arch Dermatol; 1993 Apr; 129(4):448-55. PubMed ID: 7682049
[TBL] [Abstract][Full Text] [Related]
19. Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin-332 and type XVII collagen.
Hayashi I; Shinkuma S; Shimizu S; Natsuga K; Ujiie H; Yasui C; Tsuchiya K; Nishie W; Shimizu H
Br J Dermatol; 2012 May; 166(5):1116-20. PubMed ID: 22182184
[TBL] [Abstract][Full Text] [Related]
20. Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology.
Santi CG; Gripp AC; Roselino AM; Mello DS; Gordilho JO; Marsillac PF; Porro AM
An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):33-47. PubMed ID: 31166405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]